GBA Presents: House of Gummy-!
- Thread starter stonedinvestor
- Start date
I should clarify as much as I don't care about your feelings I love you all.
That's what being a HOUSE MOTHER is all about. I take care of you whether you deserve it or not.
It has been a rollicking good time.
That's what being a HOUSE MOTHER is all about. I take care of you whether you deserve it or not.
It has been a rollicking good time.
A stock that has screened for me a couple times lately is the dreaded BROS.
This stk is very close to a B/O but I would be a 3 time sucker...
GBA UPGRADE->Dutch Bros Inc. (BROS)
NYSE - Nasdaq Real Time Price.
32.10+0.20 (+0.64%)
As of 02:20PM EST.
This stk is very close to a B/O but I would be a 3 time sucker...
GBA UPGRADE->Dutch Bros Inc. (BROS)
NYSE - Nasdaq Real Time Price.
32.10+0.20 (+0.64%)
As of 02:20PM EST.
Vz have you heard about the Trump smell? Get ready you will // guy is rotting from the inside out or something vile. I'm not making this up. People cannot stand to be near him.
See that's what's wrong with you stoney... you should care about other people here. That statement says a lot about you... you should think about it.Lol... And folks think Trump is a narcissist. I swear it's in the water up there.
HEY VAN I DON'T CARE. I AM THE MOST IMPORTANT SINGLE PERSON ON ELITE TRADER =I PAY THE BILLS-- & DO NOT CARE A WHIT ABOUT ANYBODY ELSE HERE EXCEPT FOR THE HF GUYS I KNOW.
Now that's more like it. I'll have a look, I have not checked up on it in a while. CAVA's up. Or it was last I looked.
edit... yeah $43
Another stock to watch-- This came on my screen earlier this week for the short size against it.//
Syros Pharmaceuticals (SYRS)
Yet another biopharmaceutical enterprise with the possibility of delivering game-changing therapeutics,Syros Pharmaceuticals(NASDAQ:SYRS) specializes in leveraging gene expression. As its website points out, the wrong genes being expressed at the wrong time or in the wrong amounts can lead to disease. However, Syros identified cancer patients with aberrant gene expression that can be targeted with new therapies.
It’s one of the more promising ideas among speculative penny stocks with potential. However, investors aren’t exactly confident about the underlying enterprise. Since the beginning of the year, SYRS dropped more than 22% of equity value. It’s also a risking classification as a nano-cap play with a market value of only $58 million. Drop $8 million and it becomes a nano cap.
Naturally, bears feel relatively confident in shorting SYRS but that could change. Right now, it takes roughly eight days to cover all shorts based on average trading volume. Also, Fintel identifies SYRS as one of the top 500 most-shorted securities, heightening risk for the pessimists.
Finally, analysts rate SYRS a unanimous strong buy with a $12.33 price target, projecting 348% growth. That easily makes it one of the penny stocks with upside potential.
Syros Pharmaceuticals (SYRS)
Yet another biopharmaceutical enterprise with the possibility of delivering game-changing therapeutics,Syros Pharmaceuticals(NASDAQ:SYRS) specializes in leveraging gene expression. As its website points out, the wrong genes being expressed at the wrong time or in the wrong amounts can lead to disease. However, Syros identified cancer patients with aberrant gene expression that can be targeted with new therapies.
It’s one of the more promising ideas among speculative penny stocks with potential. However, investors aren’t exactly confident about the underlying enterprise. Since the beginning of the year, SYRS dropped more than 22% of equity value. It’s also a risking classification as a nano-cap play with a market value of only $58 million. Drop $8 million and it becomes a nano cap.
Naturally, bears feel relatively confident in shorting SYRS but that could change. Right now, it takes roughly eight days to cover all shorts based on average trading volume. Also, Fintel identifies SYRS as one of the top 500 most-shorted securities, heightening risk for the pessimists.
Finally, analysts rate SYRS a unanimous strong buy with a $12.33 price target, projecting 348% growth. That easily makes it one of the penny stocks with upside potential.
couple threads ago we were on this name
WATCH-
Syros Pharmaceuticals, Inc. (SYRS)- Yesterday's find: $20 PT on a $1 stk.
1.1400+0.0400 (+3.64%)
As of 09:44AM EDT. Market open.
#274 Mar 17, 2022
WATCH-
Syros Pharmaceuticals, Inc. (SYRS)- Yesterday's find: $20 PT on a $1 stk.
1.1400+0.0400 (+3.64%)
As of 09:44AM EDT. Market open.
#274 Mar 17, 2022